Orchestrating deviations, holds, and CAPA across ERP, MES, and LIMS.

Under 21 CFR 211.192 and 21 CFR 820.100, a production or laboratory discrepancy investigation must extend beyond the immediate batch to every other batch of the same drug or device—and to related products—that may share the failure mode. In modern life sciences operations, the evidence required to answer that question never lives inside one department. Lot genealogy sits in ERP, step execution lives in MES, analytical out-of-specification and out-of-trend runs sit in LIMS, automation patches sit in ServiceNow ITSM, and controlled procedures sit in a DMS.

Traditional standalone QMS platforms treat all of those operational systems as external attachments. Investigators spend weeks copying batch numbers into spreadsheets, emailing supply chain to confirm whether quarantined lots were blocked from shipment, and closing CAPAs before IT configuration changes or SOP training assignments actually finish. When FDA or European inspectors pull overdue CAPAs, the root cause of the backlog is rarely investigator effort—it is an unorchestrated system boundary.

ProcessX by USDM Life Sciences deploys as a validated scoped application inside the ServiceNow instance you already license and staff, with embedded USDM engineers delivering your first production GxP workflows in 6–12 weeks. Because ServiceNow already sits across enterprise IT, asset, vendor, and operations routing, ProcessX turns it into the governed orchestration layer across ERP, MES, LIMS, DMS, and LMS—replacing standalone quality silos end to end or running hybrid alongside your existing document and training repositories.

In anonymized manufacturing and quality operations deployments, putting quality events and product hold visibility onto governed ServiceNow workflows aligns plant operations, supply chain, IT, and Quality around one live record graph instead of pre-release spreadsheet hunts. Optional AI stays off out of the box inside the scoped app; when configured for a workflow, AI can draft initial cross-batch impact summaries from linked records, while qualified people challenge, edit, and sign every regulated disposition.

Inspectors reviewing deviations and CAPAs under 21 CFR 211.192, 21 CFR 820.100, and ICH Q10 test whether the electronic record proves end-to-end causality: when the discrepancy was detected, which other batches were evaluated, how quarantined material was controlled prior to release, and whether corrective actions actually prevented recurrence. ProcessX generates that chain of evidence natively inside your ServiceNow tenant as the work runs.